Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Finasteride effectively reduces hair loss by decreasing androgen levels.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Male hormones worsen kidney transplant damage, but blocking them helps.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Finasteride reduces sperm count and quality and alters hormone levels in mice.

Certain Chinese herbs, especially Cacumen platycladi, can promote hair regrowth and reduce hair loss-related hormone levels in mice.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

Hormones and signaling pathways control sebaceous gland function and could help treat acne.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Hair growth is influenced by various body and external factors, and neighboring hairs communicate to synchronize regeneration.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.